Vericiguat before and after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether the drug vericiguat, taken before and after heart surgery, can help protect the heart and reduce the risk of heart failure. It may help people who have heart problems going into surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for heart surgery, such as bypass, valve repair or replacement, or major blood vessel surgery.
- Your doctor thinks you are at high risk for heart failure or your heart is not pumping as well as it should.
- Your resting blood pressure is at least 100 mmHg.
- You are able to attend follow-up visits for 6 months after surgery.
- You have not taken certain medications (like sildenafil or tadalafil) recently, and you do not have severe liver or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies vericiguat-like stimulation (a type of medicine that affects blood-vessel signaling) around the time of planned open-heart surgery. It aims to see whether this can change blood-vessel “reactivity” and reduce injury to organs during and after surgery.
This trial tests whether starting the medication vericiguat soon after a heart attack can help people whose hearts are weakened (ejection fraction 45% or lower) and who developed heart failure. Vericiguat is an oral medicine that may reduce strain on the heart and improve outcomes when given early.
This study tests a medicine called vericiguat (a pill) to see if it can improve the heart's shape and function in people with heart failure and a weakened pump. You would keep taking your usual heart medications plus the study drug.
This study tests whether the drug vericiguat helps people with heart failure after a heart attack. The trial looks at people whose heart pumping is weak and who have symptoms despite standard treatment.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This study tests a drug called vericiguat, which may help people with heart failure and a leaky tricuspid valve. It aims to improve heart function and reduce symptoms.
Hear when a new Cardio Vascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.